SPRY Insider Trading
Insider Ownership Percentage: 40.10%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $38,255,298.78
ARS Pharmaceuticals Insider Trading History Chart
This chart shows the insider buying and selling history at ARS Pharmaceuticals by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
ARS Pharmaceuticals Share Price & Price History
Current Price: $14.88
Price Change: +0.30 (1.20%)
As of 04/17/2025 05:00 PM ET
ARS Pharmaceuticals Insider Trading History
ARS Pharmaceuticals Institutional Trading History
Data available starting January 2016
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for severe allergic reactions. The company is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for the emergency treatment of Type I allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.
Read More on ARS Pharmaceuticals
Today's Range
Now: $14.88
52 Week Range
Now: $14.88
Volume
1,550,196 shs
Average Volume
1,155,748 shs
Market Capitalization
$1.46 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.86
Who are the company insiders with the largest holdings of ARS Pharmaceuticals?
ARS Pharmaceuticals' top insider shareholders include:
- Ra Capital Management, LP (Director)
- James E Flynn (Major Shareholder)
- Sarina Tanimoto (Insider)
- Richard E Lowenthal (CEO)
- Peter A Thompson (Director)
- Laura Shawver (Director)
- Justin Chakma (Insider)
- Alexander A Fitzpatrick (Insider)
- Kathleen D Scott (CFO)
- Eric Karas (Insider)
- Brian Dorsey (COO)
Learn More about top insider investors at ARS Pharmaceuticals.
Who are the major institutional investors of ARS Pharmaceuticals?
Which major investors are selling ARS Pharmaceuticals stock?
In the last quarter, SPRY stock was sold by these institutional investors:
- SG Americas Securities LLC
In the last year, company insiders that have sold ARS Pharmaceuticals company stock include:
- Ra Capital Management, LP (Director)
- James E Flynn (Major Shareholder)
- Sarina Tanimoto (Insider)
- Richard E Lowenthal (CEO)
- Peter A Thompson (Director)
- Laura Shawver (Director)
- Justin Chakma (Insider)
- Alexander A Fitzpatrick (Insider)
- Kathleen D Scott (CFO)
Learn More investors selling ARS Pharmaceuticals stock.
Which major investors are buying ARS Pharmaceuticals stock?
During the last quarter, SPRY stock was purchased by institutional investors including:
- Janney Montgomery Scott LLC
- Rhumbline Advisers
- GAMMA Investing LLC
During the last year, these company insiders have bought ARS Pharmaceuticals stock:
- Ra Capital Management, LP (Director)
- James E Flynn (Major Shareholder)
Learn More investors buying ARS Pharmaceuticals stock.